Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 13,488,000 | 10,389,000 | 7,064,000 | 3,567,000 | 18,106,000 |
| Depreciation Amortization | 1,158,000 | 866,000 | 567,000 | 283,000 | 1,098,000 |
| Income taxes - deferred | -119,000 | -95,000 | -116,000 | 15,000 | -393,000 |
| Accounts receivable | 1,192,000 | 770,000 | 190,000 | -191,000 | -1,397,000 |
| Accounts payable and accrued liabilities | 47,000 | -115,000 | -67,000 | -239,000 | 226,000 |
| Other Working Capital | 1,546,000 | 1,697,000 | 1,185,000 | -5,000 | 1,495,000 |
| Other Operating Activity | -265,000 | -4,000 | 292,000 | 700,000 | 2,115,000 |
| Operating Cash Flow | $17,047,000 | $13,508,000 | $9,115,000 | $4,130,000 | $21,250,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -10,880,000 | -8,374,000 | -4,655,000 | -1,575,000 | -11,728,000 |
| PPE Investments | -748,000 | -579,000 | -381,000 | -177,000 | -747,000 |
| Purchase Of Investment | -357,000 | -357,000 | -357,000 | -357,000 | N/A |
| Investing Cash Flow | $-11,985,000 | $-9,310,000 | $-5,393,000 | $-2,109,000 | $-12,475,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 6,249,000 | 6,249,000 | 349,000 | 95,000 | 10,686,000 |
| Debt Repayment | -1,981,000 | -1,251,000 | -290,000 | -126,000 | -997,000 |
| Common Stock Issued | 208,000 | 180,000 | 120,000 | 92,000 | 319,000 |
| Common Stock Repurchased | -11,001,000 | -10,001,000 | -9,001,000 | -8,000,000 | -10,002,000 |
| Dividend Paid | -2,455,000 | -1,836,000 | -1,213,000 | -587,000 | -1,874,000 |
| Other Financing Activity | -745,000 | -718,000 | -139,000 | -87,000 | -4,016,000 |
| Financing Cash Flow | $-9,725,000 | $-7,377,000 | $-10,174,000 | $-8,613,000 | $-5,884,000 |
| Exchange Rate Effect | 41,000 | 137,000 | 86,000 | 56,000 | -67,000 |
| Beginning Cash Position | 12,851,000 | 12,851,000 | 12,851,000 | 12,851,000 | 10,027,000 |
| End Cash Position | 8,229,000 | 9,809,000 | 6,485,000 | 6,315,000 | 12,851,000 |
| Net Cash Flow | $-4,622,000 | $-3,042,000 | $-6,366,000 | $-6,536,000 | $2,824,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 17,047,000 | 13,508,000 | 9,115,000 | 4,130,000 | 21,250,000 |
| Capital Expenditure | -748,000 | -579,000 | -381,000 | -177,000 | -747,000 |
| Free Cash Flow | 16,299,000 | 12,929,000 | 8,734,000 | 3,953,000 | 20,503,000 |